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Volume 55, Number 5 Bush 1305AGREE instrument in its original form contained 23 items
grouped into six domains with a 4-point Likert scale used to score
each item, including whether the guideline development group
included individuals from all relevant professional groups, patients’
views and preferences had been sought, and the guideline piloted
among end users.
Tools that imply a simple measure of guideline validity based
on a review of reported methodology are appealing. However,
several studies have documented that high AGREE scores do not
necessarily correlate with clinically appropriate recommendations
and, likewise, clinically sound recommendations have been pub-
lished with an incomplete description of the methodological ap-
proach.1-5 In this issue of the Journal, Huninck, and colleagues
used a survey tool from one of the six domains in the AGREE
instrument, which focuses on the presumed rigor of guideline
development as a surrogate assessment of the quality of recom-
mendations related to AAA screening that were published over a
4-year period. Despite an interest in using AGREE to achieve
clarity, the authors’ summary screening algorithm collates recom-
mendations from virtually all of the guidelines, which reflects
established areas in need of further research and contributes little
that is new to the field. The inability of AGREE or the more recent
AGREE II instrument to assess the clinical content of the recom-
mendations or the quality of the supporting evidence remainmajor
flaws of this tool and should provide a cautionary note to the
adoption of this instrument as a surrogate measure of guideline
validity by primary care providers, patients, or government offi-
cials.Notwithstanding concerns surrounding the validity of this
instrument to judge consensus statements and practice guidelines,
at risk. There currently are not enough data for recommendations
to firmly support screening these subgroups. Thus, they are left out
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whe AGREE collaborative appropriately emphasizes the value of
arefully reporting the search strategy for the literature review, the
riteria for selecting the evidence, and the methods used to formu-
ate the recommendations, including a thorough discussion of risks
nd benefits. The value of an explicit statement that the guidelines
ave been subject to external peer review is also highlighted.
doption of these and other reporting criteria by committees and
edical publications focused on the formulation and presentation
f practice guidelines should be enthusiastically supported.
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BMJ Qual Saf 2011;20:747-55.INVITED COMMENTARYRuth L. Bush, MD, MPH, Temple, Tex
“Systematic review of guidelines on abdominal aortic aneu-
rysm screening” is a well-written and timely article by Ferket and
colleagues. After extensive literature review of guidelines on ab-
dominal aortic aneurysm (AAA) screening, these authors found
only seven guidelines that provided consensus recommendations
for a one-time screening for (AAA): basically, men age 65 years and
older should be screened using duplex ultrasound. However, as
they correctly state, 90% of identified AAAs are small (3.0-3.9 cm).
Policy makers, Centers forMedicare andMedicaid, and third-party
payers need to pay attention to these data. Currently, Medicare
allows for a one-time AAA screening in the “Welcome to Medi-
care” physical, an examination performed within the first 12
months of becoming a Medicare (part B) beneficiary. Unfortu-
nately, this screening test is not always ordered or performed and
not all beneficiaries meet the criteria to order the ultrasound, which
include family history and smoking.
Other groups, besides 65-year-old and older men, deserve
research based recommendations for AAA screening. To date,
there are no published screening guidelines for AAAs in women,
persons with identified small AAAs, and younger men who may bef most guidelines, which then translates into very few persons
eing screened andminimal, if any, reimbursement for such testing
ithout firm supportive evidence. For screening efforts to improve
nd potentially vulnerable populations to be identified prior to
AA rupture, policies and guidelines for primary care providers
PCPs) must be clarified. Delivery and implementation of guide-
ines must be precise for PCPs to make informed decisions in the
are of their patients.
As a practicing vascular surgeon, this article demonstrates the
eed for more research, particularly in the subgroups mentioned
bove, so that organized screening guidelines may be developed.
ith definitive screening guidelines, PCPs will be adequately
nformed and policy makers may take heed and alter reimburse-
ent protocols We, as prominent stakeholders in the care of
atients with AAAs, need to be in the forefront of the development
f quality healthcare recommendations. It is encouraging to see
hat across continents, screening guidelines are similar. The oppor-
unity exists for combined efforts to assess risk predictionmodels of
upture and operative risk. Furthermore, cost-benefit and out-
omes analyses with large population-based studies will be possible
ith an across-continent joint research effort.
